Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C
W. Martin Kast(University of Southern California), Laurie K. Rijkee(University of Groningen), Andrew W. Woodham(Emulate (United States)), Joseph G. Skeate(University of Southern California), Annie A. Yessaian(University of Southern California), Julia R. Taylor(University of Southern California), Lynda D. Roman(University of Southern California), Heike E. Brand(University of Southern California), Greg M. McKee, Andres Μ. Salazar(Oncovir (United States)), Yvonne G. Lin(University of Southern California), Laila I. Muderspach(University of Southern California), Koji Matsuo(University of Southern California), Huyen Q. Pham(University of Southern California)
Cited by 24
Related Papers
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840